{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:19:49Z","timestamp":1793996389754,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cholangiocarcinoma (CCA) is a malignant tumor of the digestive system, characterized by its aggressive behavior and the absence of effective therapeutic biomarkers. Although recent studies have implicated AMDHD1 in tumor formation, its role in CCA development has been insufficiently explored. We utilized multiple bioinformatic datasets alongside 108 clinical samples to examine AMDHD1 expression in CCA. Then, in vitro and in vivo experiments were conducted to assess its impact on tumor growth and metastasis. Furthermore, proteomic analysis and immunoprecipitation mass spectrometry were employed to identify the downstream effectors of AMDHD1. We discovered that AMDHD1 was down-regulated in CCA and this down-regulation was associated with adverse clinicopathological features and prognosis. We also demonstrated that overexpression of AMDHD1 hindered G1\/S progression in the cell cycle and promoted apoptosis, thereby inhibiting tumor growth and metastasis. Mechanistically, we found that AMDHD1 operated in a TGF-\u03b2-dependent manner and the inhibition of TGF-\u03b2 signaling abrogated the effect of AMDHD1 overexpression on CCA cells. Specifically, AMDHD1 inhibited the ubiquitination and degradation of the SMAD4 protein through binding to the MH2 domain and synergistically enhanced SMAD2\/3 phosphorylation, which activated of TGF-\u03b2 signaling pathway and resulted in the suppression of CCA cell proliferation and migration. Our study identifies AMDHD1 as a significant prognostic biomarker and a tumor suppressor in CCA. It underscores the pivotal role of the AMDHD1\/TGF-\u03b2 signaling pathway in the development and progression of CCA.<\/jats:p>","DOI":"10.1038\/s41418-024-01361-y","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:02:09Z","timestamp":1723662129000},"page":"162-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-\u03b2 signaling pathway in cholangiocarcinoma"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-7600","authenticated-orcid":false,"given":"Zuyi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1411-9382","authenticated-orcid":false,"given":"Zhenchong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7575-5841","authenticated-orcid":false,"given":"Shanzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-3007","authenticated-orcid":false,"given":"Binglu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"1361_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","journal-title":"Lancet"},{"key":"1361_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin J, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1361_CR3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl J Med. 2010;362:1273\u201381.","journal-title":"N. Engl J Med"},{"key":"1361_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","volume":"6","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol. 2021;6:956\u201369.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1361_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02662-2","volume":"9","author":"X Jiang","year":"2018","unstructured":"Jiang X, O\u2019Reilly PF, Aschard H, Hsu YH, Richards JB, Dupuis J, et al. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun. 2018;9:260.","journal-title":"Nat Commun"},{"key":"1361_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tem.2009.12.009","volume":"21","author":"G Assi\u00e9","year":"2010","unstructured":"Assi\u00e9 G, Guillaud-Bataille M, Ragazzon B, Bertagna X, Bertherat J, Clauser E. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses. Trends Endocrinol Metab. 2010;21:325\u201334.","journal-title":"Trends Endocrinol Metab"},{"key":"1361_CR7","doi-asserted-by":"publisher","first-page":"e64483","DOI":"10.1371\/journal.pone.0064483","volume":"8","author":"Y Song","year":"2013","unstructured":"Song Y, Ahn J, Suh Y, Davis ME, Lee K. Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model. PLoS ONE. 2013;8:e64483.","journal-title":"PLoS ONE"},{"key":"1361_CR8","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2147\/CMAR.S291811","volume":"13","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Xiao Z, Sun S, Wang K, Qian J, Cui Z, et al. Integrated proteomics and bioinformatics to identify potential prognostic biomarkers in hepatocellular carcinoma. Cancer Manag Res. 2021;13:2307\u201317.","journal-title":"Cancer Manag Res"},{"key":"1361_CR9","first-page":"2160","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, Zhao L, Liu H, Luo S, Akinyemiju T, Hwang S, et al. Variants in SNAI1, AMDHD1 and CUBN in vitamin D pathway genes are associated with breast cancer risk: a large-scale analysis of 14 GWASs in the DRIVE study. Am J Cancer Res. 2020;10:2160\u201373.","journal-title":"Am J Cancer Res"},{"key":"1361_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685\u2013700.","journal-title":"Cell"},{"key":"1361_CR11","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1126\/science.1071809","volume":"296","author":"L Attisano","year":"2002","unstructured":"Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646\u20137.","journal-title":"Science"},{"key":"1361_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","volume":"14","author":"M Zhao","year":"2018","unstructured":"Zhao M, Mishra L, Deng CX. The role of TGF-\u03b2\/SMAD4 signaling in cancer. Int J Biol Sci. 2018;14:111\u201323.","journal-title":"Int J Biol Sci"},{"key":"1361_CR13","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"1361_CR14","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"1361_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13046-022-02310-8","volume":"41","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li Z, Wang S, Zhou Z, Liu C, Zhuang H, et al. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3\/p53 signaling pathway. J Exp Clin Cancer Res. 2022;41:130.","journal-title":"J Exp Clin Cancer Res"},{"key":"1361_CR16","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","volume":"33","author":"C von Mering","year":"2005","unstructured":"von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33:D433\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1361_CR17","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"1361_CR18","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1361_CR19","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-11-3549","volume":"72","author":"S Jirawatnotai","year":"2012","unstructured":"Jirawatnotai S, Hu Y, Livingston DM, Sicinski P. Proteomic identification of a direct role for cyclin d1 in DNA damage repair. Cancer Res. 2012;72:4289\u201393.","journal-title":"Cancer Res"},{"key":"1361_CR20","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","volume":"92","author":"MB Datto","year":"1995","unstructured":"Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA. 1995;92:5545\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1361_CR21","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","volume":"17","author":"S Dennler","year":"1998","unstructured":"Dennler S, Itoh S, Vivien D, Ten DP, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17:3091\u2013100.","journal-title":"EMBO J"},{"key":"1361_CR22","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1128\/MCB.19.9.5913","volume":"19","author":"BJ Warner","year":"1999","unstructured":"Warner BJ, Blain SW, Seoane J, Massagu\u00e9 J. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol Cell Biol. 1999;19:5913\u201322.","journal-title":"Mol Cell Biol"},{"key":"1361_CR23","doi-asserted-by":"publisher","first-page":"e99945","DOI":"10.15252\/embj.201899945","volume":"38","author":"B Yuan","year":"2019","unstructured":"Yuan B, Liu J, Cao J, Yu Y, Zhang H, Wang F, et al. PTPN3 acts as a tumor suppressor and boosts TGF-\u03b2 signaling independent of its phosphatase activity. EMBO J. 2019;38:e99945.","journal-title":"EMBO J"},{"key":"1361_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/mol.62.1.58","volume":"62","author":"NJ Laping","year":"2002","unstructured":"Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharm. 2002;62:58\u201364.","journal-title":"Mol Pharm"},{"key":"1361_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stem.2012.04.025","volume":"11","author":"E Willems","year":"2012","unstructured":"Willems E, Cabral-Teixeira J, Schade D, Cai W, Reeves P, Bushway PJ, et al. Small molecule-mediated TGF-\u03b2 type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell. 2012;11:242\u201352.","journal-title":"Cell Stem Cell"},{"key":"1361_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41418-021-00897-7","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu J, Ren G, Li K, Liu Z, Wang Y, Chen T, et al. The Smad4-MYO18A-PP1A complex regulates \u03b2-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma. Cell Death Differ. 2022;29:818\u201331.","journal-title":"Cell Death Differ"},{"key":"1361_CR27","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41388-022-02316-8","volume":"41","author":"P Gao","year":"2022","unstructured":"Gao P, Hao JL, Xie QW, Han GQ, Xu BB, Hu H, et al. PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer. Oncogene. 2022;41:2945\u201357.","journal-title":"Oncogene"},{"key":"1361_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41418-020-0596-y","volume":"28","author":"N Wu","year":"2021","unstructured":"Wu N, Jiang M, Liu H, Chu Y, Wang D, Cao J, et al. LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-\u03b2\/SMAD2\/3 signaling pathway. Cell Death Differ. 2021;28:219\u201332.","journal-title":"Cell Death Differ"},{"key":"1361_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/1535-7163.MCT-07-0337","volume":"7","author":"D Melisi","year":"2008","unstructured":"Melisi D, Ishiyama S, Sclabas GM, Fleming JB, Xia Q, Tortora G, et al. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther. 2008;7:829\u201340.","journal-title":"Mol Cancer Ther"},{"key":"1361_CR30","doi-asserted-by":"publisher","first-page":"27678","DOI":"10.1074\/jbc.272.44.27678","volume":"272","author":"S Abdollah","year":"1997","unstructured":"Abdollah S, Mac\u00edas-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem. 1997;272:27678\u201385.","journal-title":"J Biol Chem"},{"key":"1361_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ng.2273","volume":"44","author":"CK Ong","year":"2012","unstructured":"Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet. 2012;44:690\u20133.","journal-title":"Nat Genet"},{"key":"1361_CR32","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet. 2013;45:1470\u20133.","journal-title":"Nat Genet"},{"key":"1361_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/1097-0142(20010401)91:7<1332::AID-CNCR1136>3.0.CO;2-4","volume":"91","author":"P Argani","year":"2001","unstructured":"Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer. 2001;91:1332\u201341.","journal-title":"Cancer"},{"key":"1361_CR34","doi-asserted-by":"crossref","unstructured":"Papoutsoglou P, Louis C, Coulouarn C. Transforming Growth Factor-Beta (TGF\u03b2) signaling pathway in cholangiocarcinoma. Cells. 2019;8:960.","DOI":"10.3390\/cells8090960"},{"key":"1361_CR35","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.gastro.2015.11.039","volume":"150","author":"X Mu","year":"2016","unstructured":"Mu X, Pradere JP, Aff\u00f2 S, Dapito DH, Friedman R, Lefkovitch JH, et al. Epithelial transforming growth factor-\u03b2 signaling does not contribute to liver fibrosis but protects mice from cholangiocarcinoma. Gastroenterology. 2016;150:720\u201333.","journal-title":"Gastroenterology"},{"key":"1361_CR36","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1021\/bi047326v","volume":"44","author":"CM Seibert","year":"2005","unstructured":"Seibert CM, Raushel FM. Structural and catalytic diversity within the amidohydrolase superfamily. Biochemistry. 2005;44:6383\u201391.","journal-title":"Biochemistry"},{"key":"1361_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111253","volume":"40","author":"B Guo","year":"2022","unstructured":"Guo B, Friedland SC, Alexander W, Myers JA, Wang W, O\u2019Dell MR, et al. Arid1a mutation suppresses TGF-\u03b2 signaling and induces cholangiocarcinoma. Cell Rep. 2022;40:111253.","journal-title":"Cell Rep"},{"key":"1361_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-019-1143-x","volume":"38","author":"Q Liang","year":"2019","unstructured":"Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res. 2019;38:159.","journal-title":"J Exp Clin Cancer Res"},{"key":"1361_CR39","doi-asserted-by":"publisher","first-page":"C823","DOI":"10.1152\/ajpcell.00053.2003","volume":"285","author":"BA Roelen","year":"2003","unstructured":"Roelen BA, Cohen OS, Raychowdhury MK, Chadee DN, Zhang Y, Kyriakis JM, et al. Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation. Am J Physiol Cell Physiol. 2003;285:C823\u201330.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1361_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.celrep.2014.09.020","volume":"9","author":"H Demagny","year":"2014","unstructured":"Demagny H, Araki T, De Robertis EM. The tumor suppressor Smad4\/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-\u03b2 signaling. Cell Rep. 2014;9:688\u2013700.","journal-title":"Cell Rep"},{"key":"1361_CR41","doi-asserted-by":"crossref","unstructured":"Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-pathological importance of TGF-\u03b2\/Phospho-Smad signaling during human hepatic fibrocarcinogenesis. Cancers. 2018;10:183.","DOI":"10.3390\/cancers10060183"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01361-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T08:51:41Z","timestamp":1737103901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1361"],"URL":"https:\/\/doi.org\/10.1038\/s41418-024-01361-y","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All experimental protocols was approved by the Ethics Association of Peking Union Medical College Hospital and Guangdong Provincial People\u2019s Hospital. The number of the ethical approval was I-23PJ274. All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments. All enrolled patients had signed the informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}